IL6 and ocular melanoma: Since IL-6 shows similar dynamics among the BMSC treated with Treg-CM, Non-CM and OM, it may not be the primary driver of osteogenesis by the Treg secretome, while only affecting osteogenic differentiation in a context-dependent manner.